SMYD3 and breast carcinoma: After initial hit identification in vitro, we purchased and tested five novel small molecule SMYD3 inhibitors and discovered that Inhibitor-4 significantly reduces breast cancer proliferation, arrests the cell cycle, and induces apoptosis without impacting wild type cells.